InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Hamdy Ahmed MD, Chairman & CEO. Insider active across 1 companies, notably Vincerx Pharma, Inc.. Aggregated, 4 filings have been published. Total volume traded: €283k. The latest transaction was disclosed on 22 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€57,2756,450 shares@ €8.87990.60% mcap40.5% of flow
Common Stock
SEC:0000899243-21-049763·
Ideal exit: 18 Sept 2022 (T+270)
€57,2756,450 shares@ €8.87990.60% mcap20.3% of flow
Common Stock
SEC:0000899243-21-049763:0·
Ideal exit: 18 Sept 2022 (T+270)
€84,0117,830 shares@ €10.72940.88% mcap59.5% of flow
Common Stock
SEC:0000899243-21-026820·
Ideal exit: 26 Mar 2022 (T+270)
€84,0117,830 shares@ €10.72940.88% mcap29.7% of flow
Common Stock
SEC:0000899243-21-026820:0·
Ideal exit: 26 Mar 2022 (T+270)
4 of 4 declarations
About Hamdy Ahmed MD
Hamdy Ahmed MD is the Chief Executive Officer of Vincerx Pharma, Inc. In this role, he is responsible for the strategic direction and operations of the company. His experience in the pharmaceutical sector enables him to lead innovative initiatives and foster Vincerx's growth. He plays a key role in developing new therapeutic solutions.
